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INTRODUCTION 
 
Portal hypertension- a major hallmark of cirrhosis is defined as a 
portal pressure gradient exceeding 5-10 mm Hg. In portal hypertension, 
portosystemic collaterals decompress the portal circulation and give rise to 
varices. Development of esophageal varices and gastrointestinal bleeding 
represents a serious consequence in patients with portal hypertension. At the 
time of diagnosis of liver cirrhosis, esophageal varices are present in about 
40% of patients with compensated disease and in 60% of those with 
decompensated disease and ascites. 1, 2 
In patients with liver cirrhosis who do not have detectable esophageal 
varices, the latter appear at a rate of nearly 5% per year. 3–5 Also, the size of 
varices tends to increase with time. It has been estimated that among those 
with small esophageal varices, nearly 12% progress to large varices 
annually.3 
The annual incidence of first variceal bleeding has been estimated to 
be around 4% in non-selected patients with cirrhosis of the liver who have 
not bled previously. 6, 7 It has been shown that the risk of variceal bleeding is 
related to the size of esophageal varices, 8 with large esophageal varices 
being at a greater risk; this is possibly due to a higher variceal wall tension 
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in large esophageal varices. 9 Thus, annual incidence of gastrointestinal 
bleeding is only 1–2% in patients without varices, 5% in those with small 
esophageal varices and 15–20% in patients with large esophageal varices. 10 
Mortality rate of an episode of variceal bleeding is around 20–25% 
within the first week. 11 This figure may even be an underestimation because 
some patients die of massive variceal bleeding before reaching the hospital. 
Thus, prevention of such bleeding may be expected to improve the survival 
of these patients. Long-term administration of beta-adrenergic receptor 
antagonists has been shown to reduce the incidence of first variceal bleeding 
in patients with large esophageal varices.6 However, because this treatment 
is not free of adverse effects, 11 it should be used only for patients with large 
esophageal varices. 12, 13 It is currently recommended that patients with liver 
cirrhosis undergo a screening endoscopy to look for the presence of 
esophageal varices 14, 15 and, if present, be treated with beta-adrenergic 
receptor antagonists. These recommendations imply a large workload on 
endoscopic units and a significant cost burden on patients with liver 
cirrhosis. As the prevalence of large esophageal varices is only 9–36% in 
patients with cirrhosis who have not bled, a large number of invasive 
endoscopic procedures turn out to be negative. Thus, there is a need for non-
invasive means to diagnose or predict the presence or absence of large 
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esophageal varices. Availability of such methods may help limit the number 
of endoscopic procedures performed for detection of large esophageal 
varices. 
Several studies have evaluated possible non-invasive markers of large 
esophageal varices in patients with cirrhosis and have found platelet count, 
splenomegaly, advanced Child status, serum albumin and high portal vein 
diameter at ultrasonography to be useful for this purpose. 1, 16–24 Such 
predictive factors may be expected to vary in different populations because 
of differences in the etiology of liver cirrhosis, severity of liver disease and 
nutritional status. Data on this aspect in Indian patients with liver cirrhosis, 
who usually present late, have a poorer nutritional status and have a fair 
proportion with viral etiology, are limited.         
Therefore the study was conducted to evaluate the utility of various 
clinical, biochemical and ultrasonographic parameters for predicting the 
presence of  large esophageal varices in patients with portal hypertension. 
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LITERATURE REVIEW 
 
PORTAL HYPERTENSION  
Definition: A persistent pressure elevation of >12 mmHg in the portal vein 
circulation, dilation of the portal vein to >13 mm or an increase in the portal 
pressure gradient of >7 mmHg (difference between the pressure of the portal 
vein and that of the inferior vena cava) is termed portal hypertension. The 
portal vein is 5- 8 cm long with a diameter of 1.2 + 0.2 (or 0.97) cm.(29) 
                 Portal hypertension syndrome is caused by increased resistance in 
the portohepatic circulation and an increase in the splanchnic vein blood 
flow. The increase in vascular resistance is the decisive factor and, in the 
majority of cases, is even the sole cause. It can be functional and reversible 
as well as structural and irreversible. Blood flow correlates directly with 
vessel diameter to the 4th power; i. e. small radial changes cause large 
changes to vessel resistance. An increase in the blood flow may favour the 
occurrence of portal hypertension or enhance its clinical development. 
 Portal hypertension is classified according to the localization of the 
flow resistance. Increases in pressure in the portal vascular system are 
rapidly transferred to the preceding vascular sections, since the portal vein 
does not possess any venous valves. Depending on whether the localization 
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lies before, within or beyond the liver, the portal hypertension is broken 
down into prehepatic, intrahepatic and posthepatic blocks. The intrahepatic 
form is further subdivided into a presinusoidal, sinusoidal and postsinusoidal 
rise in resistance.  
NON-PARENCHYMATOUS PORTAL HYPERTENSION 
1. PREHEPATIC PORTAL HYPERTENSION 
2. INTRAHEPATIC PORTAL HYPERTENSION 
 A. PRESINUSOIDAL BLOCK 
PARENCHYMATOUS PORTAL HYPERTENSION 
 B. SINUSOIDAL BLOCK 
 C. POSTSINUSOIDAL BLOCK 
3. POSTHEPATIC PORTAL HYPERTENSION 
ESOPHAGEAL VARICES: 
If esophagogastric varices did not form and bleed, portal hypertension would 
be of virtually no clinical significance. The major blood supply to 
oesophageal varices is the left gastric vein. The posterior branch usually 
drains into the azygos system, whereas the anterior branch communicates 
with varices just below the oesophageal junction and forms a bundle of thin 
parallel veins that run in the junction area and continue as large tortuous 
veins in the lower esophagus. There are four layers of veins in the 
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esophagus. Intraepithelial veins may correlate with the red spots seen on 
endoscopy and which predict variceal rupture. The superficial venous plexus 
drains into larger, deep intrinsic veins. Perforating veins connect the deeper 
veins with the fourth layer which is the adventitial plexus. Typical large 
varices arise from the main trunks of the deep intrinsic veins and these 
communicate with gastric varices. The connection between portal and 
systemic circulation at the gastro-oesophageal junction is extremely 
complex. Its adaptation to the cephalad and increased flow of portal 
hypertension is ill-understood. A palisade zone is seen between the gastric 
zone and the perforating zone. In the palisade zone, flow is bidirectional and 
this area acts as water shed between the portal and azygos systems. 
Turbulent flow in perforating veins between the varices and the 
periesophageal veins at the lower end of the esophagus may explain why 
rupture is frequent in this region. Recurrence of varices after endoscopic 
sclerotherapy may be related to the communications between various venous 
channels or perhaps to enlargement of veins in the superficial venous plexus. 
Failure of sclerotherapy may also be due to failure to thrombose the 
perforating veins. 
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Other manifestations of portal hypertension: 
GASTRIC VARICES 
 These are largely supplied by the short gastric veins and drain into the 
deep intrinsic veins of the esophagus. They are particularly prominent in 
patients with extrahepatic portal obstruction.  
PORTAL HYPERTENSIVE GASTROPATHY  
 This is almost always associated with cirrhosis and is seen in the 
fundus and body of the stomach. Histology shows vascular ectasia in the 
mucosa. The risk of bleeding is increased, for instance from non-steroidal 
anti-inflammatory drugs (NSAIDs). These gastric changes may be increased 
after sclerotherapy. They are relieved only by reducing the portal pressure. 
Gastric antral vascular ectasia is marked by increased arteriovenous 
communications between the muscularis mucosa and dilated precapillaries 
and veins. Gastric mucosal perfusion is increased. This must be 
distinguished from portal hypertensive gastropathy. It is not directly related 
to portal hypertension, but is influenced by liver dysfunction. 
PORTAL HYPERTENSIVE INTESTINAL VASCULOPATHY 
 Chronic portal hypertension may not only be associated with discrete 
varices but with a spectrum of intestinal mucosal changes due to 
abnormalities in the microcirculation.  
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CONGESTIVE JEJUNOPATHY AND COLONOPATHY  
Similar changes are seen in the duodenum and jejunum. Histology 
shows an increase in size and number of vessels in jejunal villi. The mucosa 
is edematous, erythematous and friable. Congestive colonopathy is shown by 
dilated mucosal capillaries with thickened basement membranes but with no 
evidence of mucosal inflammation. 
CLINICAL FEATURES OF PORTAL HYPERTENSION 
Cirrhosis is the commonest cause. Past abdominal inflammation, 
especially neonatal, is important in extra-hepatic portal block. Clotting 
disease and drugs, such as sex hormones, predispose to portal and hepatic 
venous thrombosis. 
Haematemesis is the commonest presentation. The number and 
severity of previous haemorrhages, associated confusion or coma and blood 
transfusion should be noted. Melena, without haematemesis, may result from 
bleeding varices. The stigmata of cirrhosis include jaundice, vascular spiders 
and palmar erythema. Anaemia, ascites and precoma should be noted. 
Abdominal wall veins:  
In intra-hepatic portal hypertension, some blood from the left branch 
of the portal vein may be deviated via para-umbilical veins to the umbilicus, 
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where it reaches veins of the caval system. In extra-hepatic portal 
obstruction, dilated veins may appear in the left flank. 
Distribution and direction: 
Prominent collateral veins radiating from the umbilicus are termed 
Caput Medusae. This is rare and usually only one or two veins, frequently 
epigastric, are seen. The blood flow is away from the umbilicus, whereas in 
inferior vena caval obstruction the collateral venous channels carry blood 
upwards to reach the superior vena caval system. Tense ascites may lead to 
functional obstruction of the inferior vena cava and cause difficulty in 
interpretation. 
Murmurs: 
A venous hum may be heard, usually in the region of the xiphoid 
process or umbilicus. A thrill, detectable by light pressure, may be felt at the 
site of maximum intensity and is due to blood rushing through a large 
umbilical or para-umbilical channel to veins in the abdominal wall. A 
venous hum may also be heard over other large collaterals such as the 
inferior mesenteric vein. An arterial systolic murmur usually indicates 
primary liver cancer or alcoholic hepatitis. The association of dilated 
abdominal wall veins and a loud venous murmur at the umbilicus is termed 
the Cruveilhier–Baumgarten syndrome. This may be due to congenital 
 10
patency of the umbilical vein, but more usually to well-compensated 
cirrhosis. The para-xiphoid umbilical hum and Caput Medusae indicate 
portal obstruction beyond the origin of the umbilical veins from the left 
branch of the portal vein. They therefore indicate intra-hepatic portal 
hypertension (cirrhosis). 
Spleen: 
The spleen enlarges progressively. The edge is firm. It is larger in 
young people and in macronodular rather than micronodular cirrhosis. An 
enlarged spleen is the single most important diagnostic sign of portal 
hypertension. If the spleen cannot be felt or is not enlarged on imaging, the 
diagnosis of portal hypertension is questionable. The peripheral blood shows 
a pancytopenia associated with an enlarged spleen (secondary 
‘hypersplenism’). This is related more to reticulo-endothelial hyperplasia 
than to the portal hypertension and is unaffected by lowering the pressure by 
a porta-caval shunt. 
Liver: 
A small liver may be as significant as hepatomegaly, and size should 
be evaluated by careful percussion. It correlates poorly with the height of 
portal pressure. Liver consistency, tenderness or nodularity should be 
 11
recorded. A soft liver suggests extra-hepatic portal venous obstruction. A 
firm liver supports cirrhosis. 
Ascites: 
The portal hypertension raises the capillary filtration pressure, and 
determines fluid localization to the peritoneal cavity. Ascites in cirrhosis 
always indicates liver cell failure in addition to portal hypertension. 
Rectum: 
Anorectal varices are found in 44% of cirrhotic patients, increasing in 
those who have bled from oesophageal varices. They must be distinguished 
from simple hemorrhoids which are prolapsed vascular cushions and which 
do not communicate with the portal system. 
DIAGNOSIS OF PORTAL HYPERTENSION 
Investigation frequently needs to explore  
(1) presence of portal hypertension 
(2) etiology 
(3) severity 
(4) complications  
Laboratory parameters:  
1. Thrombocytopenia (< 100,000/ mm3) can be taken as evidence of a 
splenomegaly due to portal hypertension;  
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2. Decreased hemoglobin values can be seen as a sign of a continuous 
loss of blood. 
3. Testing for occult blood in faeces. 
4. Elevated ammonia values hint at an existing shunt circulation.  
5. Cholinesterase provides information on the functioning of the liver, 
facilitating a prognosis. 
             Tomography of the azygos vein may show enlargement as the 
collateral flow enters the azygos system. A widened left para-vertebral 
shadow may be due to lateral displacement of the pleural reflection between 
the aorta and vertebral column by a dilated hemi azygos vein. Massively 
dilated para-oesophageal collaterals may be seen on the chest radiograph as 
a retro-cardiac posterior mediastinal mass. 
Barium studies: 
 Oesophageal varices are seen as filling defects in the regular contour 
of the esophagus. They are most often in the lower third, but may spread 
upwards so that the entire esophagus is involved. Widening and finally gross 
dilatation are helpful signs. Gastric varices pass through the cardia, line the 
fundus in a worm-like fashion and may be difficult to distinguish from 
mucosal folds. Occasionally gastric varices are seen as a lobulated mass in 
the gastric fundus simulating a carcinoma.  
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Endoscopy 
 Esophagogastroscopy is considered to be the gold standard diagnostic 
procedure of choice for the detection of oesophageal or gastric varices. This 
examination should always be extended to the antrum and the duodenum, 
since varices can also occur there. Endoscopy allows the detection of 
oesophageal varices at an early stage of development. It also enables an 
assessment to be made of the size and preferred localization of the varices as 
well as imaging the surface of these veins.  
 The larger the varix the more likely it is to bleed. Colour is extremely 
important. Varices usually appear white and opaque. Red colour correlates 
with blood flow through dilated sub-epithelial and communicating veins. 
Dilated sub-epithelial veins may appear as raised cherry-red spots and red 
wheal markings (longitudinal dilated veins resembling whip marks). They 
lie on top of large sub-epithelial vessels. The haemocystic spot is 
approximately 4 mm in diameter. It represents blood coming from the 
deeper extrinsic veins of the esophagus straight out towards the lumen 
through a communicating vein into the more superficial sub-mucosal veins. 
Red color is usually associated with larger varices. All these colour changes, 
and particularly the red colour sign, predict variceal bleeding. Intra-observer 
error may depend on the skill and experience of the endoscopist. On the 
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whole, agreement is good for size and red signs. Portal hypertensive 
gastropathy is seen largely in the fundus, but can extend throughout the 
stomach. It is shown as a mosaic-like pattern with small polygonal areas, 
surrounded by a whitish-yellow depressed border. Red point lesions and 
cherry-red spots predict a high risk of bleeding. Black–brown spots are due 
to intra-mucosal haemorrhage. 
Ultrasonography: Ultrasonogram of abdomen provides clue to portal 
hypertension 
Splenomegaly (> 4 ×7 × 11 cm)  
  Dilation of the portal vein (> 13 mm) 
  Dilation of the splenic vein (> 10 mm) 
  Dilation of the ventricular coronary vein (> 6 mm) 
  Restricted respiratory modulation of the vascular width of up to 3 mm 
(increase on inspiration and decrease on expiration) regarding the 
portal vein and more particularly the splenic vein and the superior 
mesenteric vein. Decrease in width of the lumen by more than 50% on 
exhalation -  absence of portal hypertension 
 Jump in caliber of the portal vein 
 Reversal of flow in portal vessels 
 Stasis of the gall bladder and gastric walls 
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 Visible evidence of collaterals 
 Recanalization of the umbilical vein  
 Cavernous transformation of the portal vein 
 Endoscopic ultrasound is ideally suited for displaying intramural and 
perimural oesophageal varices. Endoscopic colour Doppler sonography is 
another promising procedure, particularly for demonstrating a (still) evident 
variceal perfusion. 
Doppler effect is produced by changes in wavelength due to the reflection 
of sound on moving particles (e. g. erythrocytes). Consequently, the 
direction of flow (away from or towards the sound source) as well as the 
flow rate in arterial and venous vessels can be determined. The flow volume 
is then calculated by additional sonographic measurement of the vessel 
diameter. It has been shown that the rate of flow is clearly dependent upon 
the respiratory activity, so that an increase in blood flow velocity can be 
determined with maximum expiration as well as postprandially (normal 
value: 18-30 cm/sec).  
 In case of a distinct reduction in the flow rate, the flow direction may 
be reversed (hepatopetal to hepatofugal). Blood flow in the portal venous 
system is normally hepatopetal as opposed to pulsatile (or only slightly 
pulsatile) and follows an increased expiration flow rate. Undulating blood 
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flow when inhaling (hepatopetal) and exhaling (hepatofugal) is evidence of 
portal hypertension.  
Congestion index (CI):  
 This parameter is the most reliable indicator of portal hypertension. It 
relates the portal cross-sectional area to the portal blood flow rate. The CI 
ranks higher than the direct pressure level in the diagnostics of the portal 
system and the HVPG. These three techniques (in this order) are considered 
to be the gold standard in early diagnosis of portal hypertension. CI levels of 
>0.1 are associated with excessive portal pressure with >95% sensitivity and 
specificity. Sonographic imaging of cavernous transformation in the portal 
vein usually shows beaded varicose collaterals in the hepatoduodenal 
ligament. 
 Arteriography:  This technique is costly, time-consuming and high-
risk. The injection of contrast medium into the spleen is carried out either 
percutaneously (sonography-guided) or, preferably, by laparoscopy, this 
method ensures access to the collaterals if radiological obliteration is 
planned. 
A. Indirect splenoportography via the femoral artery is not only very 
important, but also low-risk.  
B. Hepatic vein phlebography  
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C. Other procedures that can be applied are indirect mesentericoportography, 
transjugular or transhepatic splenoportography, umbilical portography and 
scintigraphic splenoportography. 
MEASUREMENT OF PORTAL PRESSURE 
Direct measurement: 
 Direct measurements of portal pressure are invasive investigations 
based on the surgical, percutaneous transhepatic, or transvenous 
(transjugular) catheterization of the portal vein. Because of this 
inconvenience and the associated surgical or hemorrhagic risk, direct 
measurements of portal pressure are rarely used. 
Indirect measurement: 
 The indirect and safe approach of hepatic vein catheterization, with 
measurements the WHVP and FHVP, is the preferred technique to estimate 
portal pressure. The normal HVPG value is between 1-5 mm of Hg. Pressure 
higher than this implies portal hypertension regardless of clinical evidence. 
HVPG of more than 10 is predictive of the development of complications. 
HVPG of more than 12 mm of Hg is threshold pressure for variceal rupture. 
The main advantages of HVPG are its simplicity, reproducibility and safety. 
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PATHOPHYSIOLOGY OF VARICEAL HEMORRHAGE 
 Two theories have been proposed to explain variceal bleeding. The 
erosion theory suggested that varices bleed when external trauma to their 
thin and fragile walls is caused by the deglutition of solid food or by 
gastroesophageal reflux. This theory has been abandoned because of a lack 
of objective evidence. No relationship between eating and bleeding has been 
proved, nor is the incidence of reflux and esophagitis greater in patients with 
bleeding varices than in those without bleeding.  
On the contrary, the so-called explosion hypothesis suggests that the 
main cause of bleeding is excessive hydrostatic pressure inside the varices, 
which is a consequence of increased portal pressure. In support of this 
hypothesis, many studies have shown that variceal bleeding does not occur 
before the HVPG reaches a threshold value of 12 mm Hg. In addition, since 
the introduction of endoscopic techniques to measure variceal pressure, new 
observations have been made to support the role of increased intravariceal 
pressure in variceal rupture. Therefore, variceal pressure is higher in patients 
with previous bleeding than in nonbleeders, and longitudinal studies have 
shown that variceal pressure is a good prognostic indicator of the risk for 
bleeding and of the response to pharmacologic therapy. Variceal pressure, 
size, and wall thickness can be integrated in the concept of wall tension, the 
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inwardly directed force exerted by the variceal wall to oppose an outwardly 
directed force that causes further distention. Variceal bleeding occurs when 
the tension exerted by the thin wall of a varix is beyond a critical value, as 
determined by the elastic limit of the vessel. At this point, the variceal wall 
cannot resist further dilatation, and variceal rupture occurs.  
According to Frank's modification of Laplace's law, variceal wall 
tension (WT) can be defined as: WT = (Pi - Pe) × r/w in which Pi is the 
intravariceal pressure, Pe the pressure in the esophageal lumen, r the radius 
of the varix, and w the thickness of its wall. 
 The natural history of portal hypertension can be described as a 
function of variceal wall tension. Once wall tension increases to values 
exceeding the elastic limit of a varix, the patient experiences a first episode 
of bleeding. After this, the patient remains at a high risk for rebleeding 
unless wall tension is decreased. Similarly, primary prophylaxis protects the 
patient from bleeding by preventing or delaying variceal wall tension from 
reaching the rupture point, which is achieved by decreasing portal pressure 
and portal–collateral blood flow. An increase in intravascular pressure, 
together with a high rate of collateral blood flow, causes varices to dilate, 
and as they dilate, their walls become thinner. At this point, any further 
 20
increase in variceal pressure or size or any defect in the variceal wall causes 
rupture and clinical hemorrhage. 
 Alcohol intake, post prandial state, physical exercise, and conditions 
that increase intra-abdominal pressure can increase portal pressure abruptly. 
In all these circumstances, repeated abrupt increases in portal pressure cause 
a progressive dilatation of varices and, therefore, increase the risk for 
variceal bleeding. Circadian variations have been observed in portal 
pressure—pressure increases during the night and decreases during the 
afternoon and evening. These physiologic variations in portal pressure may 
affect the onset of bleeding in patients at risk (those with a high variceal 
tension in resting conditions); a circadian pattern has been observed in 
variceal hemorrhage, which is more frequent at midnight, when portal 
pressure generally is increasing. In patients with cirrhosis, portal pressure is 
also increased by circumstances that worsen liver failure, such as alcoholic 
hepatitis, severe infections, and acute or chronic liver failure. 
NATURAL HISTORY OF VARICES 
Gastroesophageal varices are the most relevant portosystemic 
collaterals because their rupture results in variceal hemorrhage, the most 
common lethal complication of cirrhosis. Varices and variceal hemorrhage 
are the complications of cirrhosis that result most directly from portal 
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hypertension. Patients with cirrhosis and gastroesophageal varices have an 
HVPG of at least 10-12 mm Hg. Gastroesophageal varices are present in 
approximately 50% of patients with cirrhosis. Their presence correlates with 
the severity of liver disease, while only 40% of Child A patients have 
varices, they are present in 85% of Child C patients. Patients with primary 
biliary cirrhosis may develop varices and variceal hemorrhage early in the 
course of the disease even in the absence of established cirrhosis. It has also 
been shown that 16% of patients with hepatitis C and bridging fibrosis have 
esophageal varices. Patients without varices develop them at a rate of 5% per 
year, and the strongest predictor for development of varices in those with 
cirrhosis who have no varices at the time of initial endoscopic screening is 
an HVPG >10 mmHg. Patients with small varices develop large varices at a 
rate of 10-15% per year. Decompensated cirrhosis (Child B/C), alcoholic 
cirrhosis, and presence of red wale marks (defined as longitudinal dilated 
venules resembling whip marks on the variceal surface) at the time of 
baseline endoscopy are the main factors associated with the progression 
from small to large varices. 
Variceal hemorrhage occurs at a yearly rate of 5%- 15%, and the most 
important predictor of hemorrhage is the size of varices, with the highest risk 
of first hemorrhage (15% per year) occurring in patients with large varices. 
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Other predictors of hemorrhage are decompensated cirrhosis (Child B/C) 
and the endoscopic presence of red wale marks. Although bleeding from 
esophageal varices ceases spontaneously in up to 40% of patients, and 
despite improvements in therapy over the last decade, it is associated with a 
mortality of at least 20% at 6 weeks. 
Patients with an HVPG >20 mmHg (measured within 24 hours of 
variceal hemorrhage) have been identified as being at a higher risk for early 
rebleeding (recurrent bleeding within the first week of admission) or failure 
to control bleeding (83% vs. 29%) and a higher 1-year mortality (64% vs. 
20%) compared to those with lower pressure. Late rebleeding occurs in 
approximately 60% of untreated patients, mostly within 1-2 years of the 
index hemorrhage. 
Variceal wall tension is probably the main factor that determines 
variceal rupture. Vessel diameter is one of the determinants of variceal 
tension. At an equal pressure, a large diameter vessel will rupture while a 
small diameter vessel will not rupture. Besides vessel diameter, one of the 
determinants of variceal wall tension is the pressure within the varix, which 
is directly related to the HVPG. Therefore, a reduction in HVPG should lead 
to a decrease in variceal wall tension, thereby decreasing the risk of rupture. 
Indeed, variceal hemorrhage does not occur when the HVPG is reduced to 
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<12 mmHg. It has also been shown that the risk of rebleeding decreases 
significantly with reductions in HVPG greater than 20% from baseline. 
Patients whose HVPG decreases to <12 mmHg or at least 20% from baseline 
levels (“HVPG responders”) not only have a lower probability of developing 
recurrent variceal hemorrhage, but also have a lower risk of developing 
ascites, spontaneous bacterial peritonitis and death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24
AIMS AND OBJECTIVES 
 
1. To study the incidence of large and small esophageal varices in 
patients with liver disease.  
2. To evaluate various clinical, biochemical and ultrasonographic 
parameters in predicting the presence of large esophageal varices.  
3. To evaluate the sensitivity and specificity of each of the parameters in 
predicting large esophageal varices. 
4. Validating the platelet count / spleen diameter ratio of 909 in 
predicting large esophageal varices.   
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METHODS 
Patients: 
              Consecutive newly diagnosed patients with liver disease (cirrhosis / 
portal hypertension) with or without history of gastrointestinal bleeding 
between August 2006 and December 2008 at our institution (Department of 
digestive health and diseases, Government peripheral hospital, Anna nagar, 
Chennai) which serves as a tertiary referral center were included in this 
prospective study. Patients were asked to sign an informed consent prior to 
enrollment in the study. 
Inclusion criteria: 
 Age: 18 years to 80 years 
 Liver disease with portal hypertension 
Exclusion criteria: 
 Hepatocellular carcinoma detected by ultrasonography and/or elevated 
alpha-feto protein  
 Primary hematologic disorders 
 Active gastrointestinal bleeding on admission 
 Taking drugs for primary prophylaxis of variceal bleeding 
 History of parenteral drug addiction 
 History of EST or band ligation, TIPS  
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 Advanced co-morbidity for endoscopy 
 Previous surgical intervention for portal hypertension 
Clinical evaluation: 
             All patients underwent a detailed clinical evaluation at entry. 
Relevant history, etiology of liver disease (alcohol intake, blood transfusion 
etc), and physical characteristics including age, gender, symptoms and signs 
of liver failure (spider angioma, palmar erythema etc.), hepatomegaly, 
splenomegaly, and abdominal vein collaterals were recorded.  
              Ascites was graded as none, mild (detectable only on ultrasound), 
moderate (visible moderate symmetrical abdominal distension) or severe 
(marked abdominal distension).25 Hepatic encephalopathy was graded from 
grade 0 to IV, as per the Conn’s grading. 26 
Definition of Terms 
1. Compensated cirrhosis — patients without ascites and/or hepatic 
encephalopathy 
2. Splenomegaly — diameter of >100mm by ultrasound 
3. Normal platelet count: 150-450 x 103/ul 
Blood tests: 
            Hematological and biochemical workup included measurement of 
hemoglobin, total leukocyte count, platelet count, prothrombin time, and 
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serum concentrations of bilirubin (total and conjugated), protein, albumin, 
alanine aminotransferase and aspartate aminotransferase. For each patient, a 
modified Child-Pugh score was calculated. 27 All patients were tested for 
HBsAg and antibodies to hepatitis C virus using enzyme immunoassays to 
determine the cause of liver cirrhosis. Tests for other causes of cirrhosis 
(serum ceruloplasmin and slit lamp examination for Wilson’s disease, tests 
for autoantibodies for autoimmune liver disease, iron studies for 
hemochromatosis) were carried out only if there was a suggestive clinical 
clue. In patients with ascites, ascitic fluid was tapped under aseptic 
precautions and ascitic fluid albumin and serum-ascites albumin gradients 
were measured. Patients with SBP were treated accordingly. 
Ultrasound Doppler:  
           All patients underwent ultrasonography after over night fast and the 
following details were recorded: maximum vertical span of the liver; 
nodularity of liver surface; spleen size (length of its longest axis); diameter 
of the portal and splenic veins; presence of portal-systemic collaterals; and 
presence of ascites.  
Endoscopic evaluation:  
 All patients underwent upper gastrointestinal endoscopy for 
assessment of esophageal and gastric varices using video gastroscope 
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(Pentax) with in 2-3 days of admission. If esophageal varices were present, 
their size was graded as I-IV, using the Paquet grading system. 28 
Furthermore, patients were classified dichotomously either as having large 
esophageal varices (grade III-IV) or as not having these (no varices or grade 
I-II). Presence of gastric varices, portal hypertensive gastropathy, 
duodenopathy and rectal varices were recorded wherever appropriate. 
Gastric varices were classified according to Sarin classification as isolated 
gastric or gastroesophageal varices, i.e., gastric varices associated with 
esophageal varices. The entire clinical, laboratory, ultrasonographic and 
endoscopic assessments were completed in 4 weeks. Diagnosis of cirrhosis 
was based on clinical, biochemical, and ultrasonographic findings.  
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STATISTICAL METHODS 
 
 Univariate analysis for determining the association of various clinical, 
laborataroy and ultrasonographic variables with presence of large varices 
was performed using Student t test for continuous variables and the chi 
square tests for categorical variables. Differences were considered 
statistically significant if the two tailed p value was less than 0.05. 
 All variables that were found to be significant were studied using 
logistic regression analysis to identify independent predictors for the 
presence of such varices. 
 Receiver operating characteristic curves (ROC) analysis was 
performed on the available data set for the parameter that had the best 
predictive value of the presence of  large esophageal varices. All 
calculations were made using SPSS software (version 11 for windows; 
SPSS, Chicago, IL, USA). 
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RESULTS 
 
Patient characteristics:  
 One hundred and six patients were included in this study. Age group - 
median age: 45 years; range 18- 74. 72 were male patients with a male- 
female ratio of 2.11: 1. 
 Patient’s symptom duration was 10- 240 days with a median of 90 
days. Clinically detectable ascites was present in 50 patients and 43 had 
pedal edema. 53 patients had previous history of GI bleed in the form of 
hematemesis or malena. 53 patients had jaundice at presentation. 
 Etiology of liver disease in the study was alcohol (52), followed by 
HBV (21), Autoimmune hepatitis (5), HCV (2). Severity of liver disease 
calculated by CTP is as follows, Child A: 27, Child B: 34, Child C: 45. 
 Baseline demographic and clinical characteristics, including etiology 
of liver cirrhosis and severity of disease were shown in Table: 1 
 
TABLE: 1 CLINICAL CHARACTERISTICS OF STUDY PATIENTS 
 
 
S.no Patient characteristics No. of Pts % 
1 Sex  
 Male  72 67 
 Female  34 32 
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S.no. Patient characteristics No. of Pts % 
2 Etiology  
 Alcohol  52 49 
 Hepatitis B virus 21 19.8 
 Hepatitis C virus 2 1.8 
 Autoimmune hepatitis  5 4.7 
 Cryptogenic  6 5.6 
 Others 20 18.8 
3 Child -Pugh class 
 A 27 25.4 
 B 34 32 
 C 45 42.4 
4 Clinical findings 
 Pallor  49 46.2 
 Jaundice  53 50 
 Pedal edema 43 40.5 
 Bleed  53 50 
 Ascites   
 None  56 52.8 
 Mild  20 18.8 
 Moderate  18 16.9 
 Severe  12 11.3 
 Encephalopathy  10 9.4 
 Splenomegaly  42 39.6 
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TABLE: 2 PORTAL HYPERTENSION RELATED ENDOSCIOPIC 
FINDINGS 
 
S.No. ENDOSCIOPIC FINDINGS n % 
1 NO VARICES 29 27.3% 
2 SMALL VARICES 26 24.4% 
3 LARGE VARICES 51 48.1% 
4 ESOPHAGOGASTRIC VARICES 8 0.07% 
5 PORTAL HYPERTENSIVE GASTROPATHY 40 37.7% 
 
Endoscopic findings are shown in table 2. Seventy seven patients had 
esophageal varices (large varices in 51), 8 had esophagogastric varices. 
Forty patients had portal hypertensive gastropathy along with esophageal 
varices. None had isolated gastric varices. Further more of those patients 
with esophageal varices large varices was found in 30% of CTP class A, 
41% of CTP class B and 64% of CTP class C.(table 3) 
 
TABLE: 3 PRESENCES OF VARICES ACCORDING TO CTP CLASS 
 
S.No. CTPCLASS VARICES LARGE VARICES % 
1 A=27 17 8 29.6% 
2 B=34 27 14 41.1% 
3 C=45 33 29 64.4% 
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TABLE: 4 Relationship of various parameters with presence or absence 
of large esophageal varices on Univariate analysis 
S.no Variable  Size of the esophageal varices 
    None /small             Large      
P- value 
1 Sex  35:16 37:18 0.77 
2 Median Age  43.3 42.5 0.72 
3 Symptom duration 4870 (7-240) 4760 (7-240) - 
4 Pallor  25 24 - 
5 Jaundice  24 29 - 
6 Pedal edema 21 22 - 
7 Bleed  24 29 - 
8 Palpable spleen 3 19 - 
9 Ascites  14 36 - 
10 Etiology  
Alcohol  28 24 - 
HBV 14 7 - 
HCV 1 1 - 
AIH 3 2 - 
 
Others  11 15 - 
11 Hb 8.8(4.6-12.8) 9.1 (4 -13) 0.43 
12 WBC count 8547 
(6500-11200) 
8198 
(4500-9800) 
0.18 
13 Platelet count 202781(70000- 
463000) 
157725(58000- 
472000) 
0.02 
14 Bilirubin  2.2 (0.8-7.1) 3.1 (0.7-16.1) 0.04 
15 SGOT 93.6(25-427) 62.6(21-421) 0.08 
16 SGPT 67.8(23-285) 54(12-500) 0.30 
17 SAP 184.7 (59-403) 151.4 (56-356) 0.027 
18 Prothrombin time   0.838 
19 S.Albumin 2.7 (2-3.6) 2.7 (2.4-3.8) 0.478 
20 Ascitic  Albumin 1.5 (0.6-2.5) 1.6 (1.2-2.9) 0.24 
21 SAAG 1.18 (0.6-1.5) 1.1 (0.8-1.6) 0.66 
22 CTP Score 9 (5-13) 9 (5-13) 0.003 
23 Liver Size 11.7 (7-16) 12.1 (7-14) 0.362 
24 Spleen Size 11.17 (8.5-18) 14.9 (9.2-26) 0.0001 
25 Portal Vein Size 11.3 (8-16) 13.9 (10-17) 0.001 
26 Splenic Vein Size 7.8 (7-11) 9.2 (7-11) 0.001 
27 Collaterals 8 26  
28 Varices Columns 3(1-4) 3.2(1-4) 0.52 
29 Length 8.4 (6-12) 8.1 (6-12) 0.51 
30 Gastric Varices  1 7 - 
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On Univariate analysis Bilirubin, platelet count, CTP score, spleen size, 
portal vein size and splenic vein size were significantly associated with 
presence of large varices. Table 4 
TABLE: 5 Results of multivariate logistic regression analysis for 
predictors of presence of large esophageal varices 
S.no. Predictor P-value 
1 Bilirubin  0.08 
2 Palpable spleen 0.0001 
3 Platelet count 0.001 
4 Spleen size 0.003 
5 Portal vein size 0.001 
6 Splenic vein size 0.001 
 
Table 5 shows the results of a logistic regression analysis of 106 patients 
using the predictors found to significant on univariate analysis. On this 
analysis palpable spleen, platelet count, spleen diameter on USG, portal vein 
and splenic vein size were found to be statistically significant. 
Using the maximum χ 2 value the optimum cut off in this cohort for 
discriminating patients with large varices from those with small or no 
varices was determined. 
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 A platelet count cut-off of 1,50,000/mm3 was chosen with a 
sensitivity: 72.5% (58-83.7) and specificity of  75% (60.1-83.5). 
Positive predictive value: 63.8% (50.5-75.7) 
Negative predictive value: 70.5% (55.8-82.7) 
Similarly splenomegaly was found to be statistically significant. Spleen size 
of more than 13 cm cut-off yielded the following 
Sensitivity: 88.5% (75.8-95.4) 
Specificity: 83% (70.7-91.8) 
Positive predictive value: 83.3% (70.2-91.6) 
Negative predictive value: 70.5% (75.9-95.2) 
 
Table: 6 Sensitivity and specificity of various parameters in predicting 
varices 
PARAMETERS Sensitivity
 % 
Specificity
% 
Positive 
predictive 
value % 
Negative 
predictive 
value % 
Platelet count 
<150,000/mm3 
72.5 75 63.8 70.5 
Spleen diameter 
>13 mm 
88.5 83 83.3 70.5 
Portal vein size 
>11.5 mm 
76.5 80 78 78.6 
Splenic vein size 
>8 mm 
70.6 72.6 70.6 72.7 
Platelet / spleen 
diameter ratio 909 
98.5 99 97.6 99 
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 The above table shows the sensitivity, specificity positive predictive 
value and negative predictive value of various parameters in predicting large 
esophageal varices. The optimum cutoff is mentioned along with the 
variables. 
Receiver operating characteristic curve: 
Platelet count 
 Platelet count is an important factor in predicting the presence or 
absence of large esophageal varices. ROC curve for the predictor function 
showed an area under curve of 0.701. {95% CI (0.594-0.808)}. A platelet 
count of below 1,50,000 had a specificity of 75%. 
ROC Curve
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FIG: 7     Platelet count: Area under curve: 0.701[95% CI (0.594-0.808)] 
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Receiver operating characteristic curve: Spleen size  
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FIG: 8     Spleen size: Area under curve: 0.883 [95% CI (0.813-0.912)] 
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FIG: 9     ROC curve: Platelet/Spleen diameter ratio 
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 Spleen size is an important factor in predictor of presence or absence 
of large esophageal varices. ROC curve for the predictor function showed an 
area under curve of 0.883. Spleen size of more than 13 cm had a specificity 
of 88%. 
Platelet /spleen diameter ratio 909 
Platelet/Spleen diameter ratio is proven predictor of presence or absence of 
large esophageal varices. ROC curve for the predictor function showed an 
area under curve of 0.95.  A cut off of 909 yielded a sensitivity and 
specificity of 98.5% and 99% respectively. 
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DISCUSSION 
 
 The reason for this effort is simple: the number of patients undergoing 
screening for the presence of OV is likely going to increase in the near 
future as a result of the growing pool of patients with chronic liver disease. 
Therefore, there is a particular need for non-invasive predictors of the 
presence of varices as they might help relieve medical, social, and economic 
costs.  
 Most of the studies concerning the non-invasive diagnosis of 
OV were performed on a particular subgroup of patients while some of the 
studies lacked uniformity in OV classification or adequate statistical 
analysis, and only one study analyzed patients with compensated disease. 
Almost all of the studies were retrospective, although the only prospective 
study obtained results that were no different from those obtained in 
retrospective studies. In general, most identified decreased platelet count and 
splenomegaly as non-invasive predictors of the presence of OV. In this 
study, only simple, commonly available, reproducible parameters were 
considered.  
These data based on the information obtained from 106 patients with 
portal hypertension including 51 with large esophageal varices, showed that 
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six factors had predictive ability for the presence of large esophageal varices 
on univariate analysis. However, on multivariate analysis, only four of these, 
namely low platelet count, splenomegaly, portal vein diameter, splenic vein 
diameter, were found to have independent predictive value. The efficacy of  
splenomegaly and platelet count arrived by logistic regression analysis was 
moderate with an area under the ROC curve of 0.883 and 0.701.          
Variceal gastrointestinal bleeding is a serious complication of portal 
hypertension with significant morbidity and mortality. However, this 
complication occurs primarily in patients with large esophageal varices and 
is uncommon in those with small varices. Because the occurrence of variceal 
bleeding can be prevented using pharmacological agents like beta-adrenergic 
receptor antagonists, it is important to recognize patients who have large 
esophageal varices and are thus at a higher risk of developing variceal 
bleeding and likely to benefit from such interventions. It has therefore been 
recommended that patients with liver cirrhosis should be screened for the 
presence of large esophageal varices at the time of initial diagnosis and at 
periodic intervals thereafter throughout life. However, this recommendation 
imposes a major burden on endoscopy units and significant costs on patients.  
In view of this, efforts have been made to identify clinical, laboratory 
and imaging characteristics that may non-invasively predict the presence or 
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absence of large esophageal varices with a high degree of accuracy, either 
reducing or eliminating the need for screening endoscopy. Various 
parameters found to be important for this purpose in different studies have 
included splenomegaly, thrombocytopenia, ascites, spider naevi, hepatic 
encephalopathy, serum albumin concentration, serum bilirubin levels, 
prothrombin time, Child-Pugh score, etiology of liver disease, portal vein 
diameter, and derived measures like ratio of platelet count to splenic size.             
The four parameters found to have independent predictive ability in 
this study, namely presence of a enlarged spleen, low platelet count, portal 
and splenic vein size have been the most consistently identified predictors in 
previous studies. All the other factors that have previously been shown to 
have predictive ability in only a few studies were found to lack predictive 
power in this study. Thus, the results of this study were consistent with those 
of the previously published data. 
 According to K. C. Thomopoulos et al. study, esophageal varices were 
present in 92 patients (50%), and large varices in 33 patients (17.9%).22 
Variables associated with the presence of large esophageal varices on 
univariate analysis were the presence of ascites and splenomegaly either by 
clinical examination or by ultrasound (p<0.01) and bilirubin (p=0.01). 
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Table 7. Studies Assessing Noninvasive Predictors of Varices or Large Varices 
Author Year 
No. 
Pts 
Pts With 
Varices 
CTP Class 
A/B/C (%) 
Predictors Sensitivity Specificity
False-
Negative 
Rate 
Negative 
Rate 
Validation
Studies Assessing Noninvasive Predictors of Varices 
Fook-Hong et 
al.[30] 
1999 92 53 41/47/12 PLT < 150,000 and ascites 0.75 0.62 0.35 0.40 No 
Schepis et al.[1] 2001 143 80 59/41/0 
PLT < 100,000 or 
prothrombin < 70% or PV > 
13 mm 
0.96 0.44 0.10 0.22 External 
Schepis et al., 
validation 
2001 105 57 68/32/0 
PLT < 100,000 or 
prothrombin < 70% or PV > 
13 mm 
0.89 0.27 0.32 0.18 External 
Giannini et 
al.[23] 
2003 145 89 37/36/27 PLT/spleen ratio > 909 1.00 0.93 0.00 0.36 No 
Giannini, 2003 145 53 69/31/0 PLT/spleen ratio > 909 1.00 0.77 0.00 0.49 No 
Thomopoulos et 
al.[22] 
2003 184 92  
PLT < 118,000 or spleen > 
135 mm or ascites 
0.95 0.37 0.13 0.21 No 
Zein et al.[31] 2004 183 47 Nr PLT < 150,000 0.62 0.90 0.13 0.77 External 
Zein, validation 2003 70 26 Nr PLT < 150,000 0.62 0.86 0.21 0.69 External 
Studies Assessing Noninvasive Predictors of Large Varices 
Cottone et al.[32] 1986 213 43 Nr PV > 13 mm 0.95 0.55 0.02 0.45 No 
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Chalasani et 
al.[17] 
1999 346 70 22/48/30 
PLT < 88,000 and/or 
splenomegaly 
0.90 0.36 0.07 0.30 Internal 
Pilette et al.[19] 1999 124 59 50/24/26 PLT < 160,000 0.83 0.58 0.21 0.39 No 
Zaman et al.[20] 1999 98 20 33/50/15 PLT < 88,000 0.80 0.59 0.08 0.51 No 
Fook-Hong et 
al.[30] 
1999 92 19 41/47/12 PLT < 150,000 and ascites 1.00 0.51 0.00 0.40 No 
Madhotra et 
al.[34] 
2002 184 24 43/34/23 PLT < 68,000 0.71 0.73 0.06 0.67 No 
Madhotra[21] 2002 184 24 43/34/23 Splenomegaly 0.75 0.57 0.06 0.53 No 
Zein et al.[31] 2004 183 19 Nr PLT < 150,000 0.74 0.82 0.04 0.77 External 
Zein, validation 2003 72 9 Nr PLT < 150,000 0.88 0.76 0.02 0.69 External 
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Factors independently associated with the presence of large oesophageal 
varices on multivariate analysis were platelet count, size of spleen and 
presence of ascites by ultrasound. Using mean values as cut-off points, it is 
noteworthy that only five out of 39 patients (12.8%) with platelets 
≥118(×109/l), spleen length ≤135 mm and no ascites had varices. Moreover, 
all these patients had small sized varices. On the other hand, 15 out of 18 
patients (83.3%) with a platelet count <118×109/l, spleen length >135 mm 
and ascites had varices. Moreover, five out of those 18 patients had large 
varices (28.3%). They concluded that thrombocytopenia, splenomegaly 
and ascites are independent predictors of large oesophageal varices in 
cirrhotic patients.  
 Zaman A et al. identified platelet count <88,000 was the only 
parameter identified by univariate/multivariate analysis (p < 0.05) as 
associated with the presence of large esophageal varices or gastric varices. 33  
 According to Zaman A et al. study Platelet count and Child-Pugh 
class were independent risk factors for the presence of any varices and the 
presence of large varices. For the presence of any varices, a platelet count 
of 90,000 or less and advanced Child-Pugh class were independent risk 
factors. For large varices, a platelet count of 80,000 and advanced Child-
Pugh class were independent risk factors associated with varices. 
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 In Chalasani N et al. study, the prevalence of large esophageal varices 
was 20%.17 On multivariate analysis, splenomegaly and low platelet count 
was independent predictors of large esophageal varices. Patients with a 
platelet count of > 88,000/mm3 (median value) and no splenomegaly by 
physical examination had a risk of large esophageal varices of 7.2%. Those 
with splenomegaly or platelet count < 88,000/mm3 had a risk of large 
esophageal varices of 28% (p < 0.0001). 
 Sarwar S et al. in his study of 101 patients concluded that patients 
with serum albumin < 2.95 g/dl, platelet count < 88,000 and portal vein 
diameter > 11 mm are more likely to have high grade varices. 34 These 
patients are candidates for surveillance endoscopy. 
 Prihatini J et al , in his study of 47 patient’s, detected varices in 
76.6%.35 Using bivariate analysis, platelet count of 82,000/ul (90.9% 
sensitivity; 41.7% specificity), portal vein diameter of 1.15 cm (75% 
sensitivity; 54.5% specificity) and splenic size of 10.3 cm (83.3% 
sensitivity; 63.6% specificity) were found to be predictive factors for 
esophageal varices in liver cirrhosis. They concluded that their data showed 
that platelet count, portal vein diameter and anteroposterior splenic 
measurement can be used as non invasive parameters to detect esophageal 
varices in cirrhotic patients. 
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 Amarapurkar et al. found that presence of splenomegaly was 
associated with presence of esophageal varices but not with large esophageal 
varices. 36 
 In Sharma SK et al. study, of the 101 patients, 46 had large 
esophageal varices. 37 On univariate analysis, five variables were 
significantly associated with the presence of large esophageal varices. These 
included pallor, palpable spleen, platelet count, total leukocyte count and 
liver span on ultrasound (P = 0.031). On multivariate analysis, two of these 
parameters, namely low platelet count and presence of palpable spleen, 
were found to be independent predictors of the presence of large esophageal 
varices. A ROC using the predictor function arrived at from this analysis had 
an area under the curve of 0.760.  
 Fagundes et al. conducted a study of 111 children with portal 
hypertension38 and found esophageal varices in 60% of patients. Only 
splenomegaly showed appropriate sensitivity and negative predictive value 
(97.7% and 91.7%, respectively). He suggested this as a screening test for 
esophageal varices among cirrhotic patients. 
Platelet count spleen diameter ratio:  
 In E Giannini et al.’s study of 266 patients, the prevalence rates of OV 
were 61% and 58% in the first and second groups of patients, respectively. 23 
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The platelet count/spleen diameter ratio was the only parameter which was 
independently associated with the presence of OV in a multivariate analysis. 
A platelet count/spleen diameter ratio cut off value of 909 had 100% 
negative predictive value for a diagnosis of OV. This result was reproduced 
in the second group of patients as well as in patients with compensated 
disease. In a cost-benefit analysis, screening cirrhotic patients according to 
the “platelet count/spleen diameter ratio” was far more cost effective 
compared with the “scope all strategy”. 
 Edoardo G. Giannini et al. in his study of 218 cirrhotic patients who 
underwent screening endoscopy found esophageal varices in 54.1%.39 The 
platelet count/spleen diameter ratio had 86.0% (95% CI, 80.7–90.4%) 
diagnostic accuracy for EV, which was significantly greater as compared 
with either accuracy of platelet count alone (83.6%, 95% CI 78.0–88.3%, P 
= 0.038) or spleen diameter alone (80.2%, 95% CI 74.3–85.3%, P = 0.018). 
They concluded that the platelet count/spleen diameter ratio may be 
proposed as a safe and reproducible means to improve the management of 
cirrhotic patients who should undergo screening endoscopy for EV. 
 According to Zimbwa et al. study, 30 had oesophageal varices at 
endoscopy and 10 did not.  The median platelet count/spleen diameter ratio 
in patients with varices was 537 (range 371–670) and with no varices 2229 
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(range 1542–3174). A platelet count/spleen diameter ratio of < 909 had 
100% sensitivity and specificity for the prediction of oesophageal varices in 
these patients.  
 Jeon SW et al.’s study of 52 patients, esophageal varices were present 
in 25 patients (48%).41 On univariate analysis serum albumin, total bilirubin, 
prothrombin time, platelet count, spleen size, velocity of portal vein and 
portal vein diameter were found significant. On multivariate analysis, 
independent variables were platelet count, diameter of spleen and platelet 
count/spleen diameter ratio. Endoscopic screening for varices is 
recommended in cirrhotic patients with splenomegaly. 
 This study also validated of platelet spleen diameter ratio with a cut-
off of 909 as per Giannini et al. We found that platelet spleen diameter ratio 
of 909 was highly predictive of large esophageal varices with a sensitivity 
and specificity of 98.5% and 99% respectively in this study. The area under 
ROC curve was 0.95. The platelet count/spleen diameter ratio seems to 
represent an acceptable surrogate for clinically relevant portal hypertension.  
Other parameters: 
 Tamara Alempijevic et al. in his study of 58 patients, right lobe 
diameter: albumin and platelet count: spleen diameter ratios were 
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noninvasive parameters that provided accurate information pertinent to 
determining the presence of oesophageal varices. 42  
 Tarzamni MK et al. In his 85 cirrhotic patients, Portal hypertensive 
index > 2.08 and spleen size > 15.05 cm were the factors in identifying 
patients with a low probability of LEV who may not need upper 
gastrointestinal endoscopy. 43 
Zein31 and colleagues at the Mayo Clinic report a study of potential 
noninvasive markers of esophageal varices in a consecutive series of 183 
patients with primary sclerosing cholangitis (PSC).31 The results of the study 
show that a platelet count of  150,103/dL is associated with an odds ratio of 
6.3 (95% CI: 2.6 –15.8) for the presence of varices. This figure corresponds 
to a sensitivity and specificity of 62% and 90%, respectively, for the 
detection of esophageal varices, and a negative predictive value of 87%. 
Corresponding figures for large varices are 74%, 82%, and 96 %, 
respectively. 
These predictive characteristics of the platelet count were validated in 
a subsequent group of 72 patients with PSC. The authors suggested that a 
platelet count of < 150,103/dL may be a satisfactory marker for identifying 
patients with PSC who are likely to benefit from endoscopic screening for 
esophageal varices. Different cutoff values for the platelet count have 
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previously been reported to define significant markers for the presence of 
varices or large varices (Table 7). The lower the proportion of patients in 
Child-Pugh class A is, the lower the level of the cutoff values tends to be. In 
six studies that suggested a cutoff value of 100,000/dL, the proportion of 
patients who were in Child-Pugh class A was 41% in one, 50% in three, and 
was not reported in two; one of these last two studies was the one by Zein 
and colleagues, which included more than 50% of patients without cirrhosis. 
In contrast, in all three studies that suggested a cutoff value of 100,000/dL, 
the proportion of patients in Child-Pugh class A was 50%. Moreover, each 
of these three studies aimed at predicting large varices, whereas those that 
suggested higher cutoff values aimed at predicting varices irrespective of 
their size. Therefore the different cutoff values for the platelet count in 
predicting the presence of varices are influenced by the distribution of 
patients according to the degree of liver dysfunction.  
Although the number of studies that have assessed the value of the 
platelet count in the prediction of varices is substantial, we are still not able 
to determine a reliable cutoff for application in clinical practice. Low 
platelet count is associated with the presence of esophageal varices, and, 
consequently, that it has potential for predicting their presence. However, we 
still lack adequate information on the true dimension of the association, 
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probably because of inadvertent spectrum bias in several of the available 
studies. 
 In addition to the platelet count, other markers identified are the 
prothrombin time, albumin concentration, splenic size, and portal vein 
diameter (on ultrasound). The various predictive rules suggested are 
associated with sensitivities that range from 0.62 to 1.0 (median, 0.86); 
values are higher in studies of markers of varices (median, 0.92; range, 
0.62–1.0) than in studies of markers of large varices (median, 0.83; range 
0.71–1.0). 
 In this study, prevalence of large varices was 48.11%. Large 
esophageal varices were more often associated with low platelet count, an 
enlarged spleen, as observed in other parts of the world. And multivariate 
analysis also showed the ultrasonographic measurement of spleen, portal 
vein size and splenic vein size was also associated with large esophageal 
varices, which are likely to cause a significant bleed. This study indicate that 
it may be possible to predict the presence of large esophageal varices using 
simple and non-invasive tools like clinical examination for the presence of a 
palpable spleen and platelet count with a fairly high degree of accuracy. The 
high accuracy rates may obviate the need for endoscopy in these patients, 
restricting the use of this costly and invasive procedure to only those patients 
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with intermediate scores. Such an approach would reduce both hospital costs 
and the workload of endoscopy units. 
 The relationship of these predictors to the presence of large 
esophageal varices may be easily explained. A palpable spleen as well as 
large esophageal varices may both be related to presence of a higher portal 
pressure. Similarly, the low platelet counts in patients with large esophageal 
varices may reflect a higher rate of splenic sequestration and destruction of 
these cells consequent to a higher portal pressure.  
 This study has certain limitations. Our study group represented a 
select group of patients attending a tertiary care center and included patients 
with relatively advanced disease. It would be best applied in patients 
attending large hospitals and may not perform as well in primary care 
settings. The variable being predicted, that is, the presence of large 
esophageal varices is not completely objective and is subject to interobserver 
variation. 
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CONCLUSION 
 
1. The prevalence of large esophageal varices in our study was 48.1% 
2. Our study shows that low platelet count, splenomegaly, portal vein and 
splenic vein size are independent predictors of the presence of large 
esophageal varices in patients with cirrhosis of the liver.  
3. Use of these parameters may help identify patients with a low probability 
of large esophageal varices who may not need UGI endoscopy.  
4. This may help reduce costs and discomfort for these patients and the 
burden on endoscopy units. 
5. These predictors showed moderate efficacy in predicting the presence of 
large esophageal varices.  
6. The platelet count/spleen diameter ratio seems to represent an acceptable 
surrogate for portal hypertension. Applying the “platelet count/spleen 
diameter ratio strategy” for the detection of OV would seem to be more cost 
effective than the “scope all strategy”. Future studies are required to evaluate 
the reproducibility of the platelet count/spleen diameter ratio for the non-
invasive diagnosis of varices. 
7. If its efficacy is confirmed, it may permit institution of prophylactic 
measures like beta-adrenergic antagonists for preventing primary variceal 
 54
bleeding in patients with liver cirrhosis, without the need for costly and 
invasive investigations like gastrointestinal endoscopy. 
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